Antibiotics for exacerbations of chronic obstructive pulmonary disease
DJ Vollenweider, A Frei… - Cochrane Database …, 2018 - cochranelibrary.com
Background Many patients with an exacerbation of chronic obstructive pulmonary disease
(COPD) are treated with antibiotics. However, the value of antibiotics remains uncertain, as …
(COPD) are treated with antibiotics. However, the value of antibiotics remains uncertain, as …
[HTML][HTML] Assessing treatment success or failure as an outcome in randomised clinical trials of COPD exacerbations. A meta-epidemiological study
AG Mathioudakis, S Ananth, T Bradbury, B Csoma… - Biomedicines, 2021 - mdpi.com
A recently published ERS core outcome set recommends that all trials of COPD
exacerbation management should assess the treatment success (or “cure” of the …
exacerbation management should assess the treatment success (or “cure” of the …
[图书][B] Methodology and feasibility of randomised controlled trials evaluating precision medicine interventions for acute exacerbations of chronic obstructive pulmonary …
A Mathioudakis - 2022 - search.proquest.com
Abstract Chronic Obstructive Pulmonary Disease (COPD) is a burdensome, long-term lung
disease, causing persistent respiratory symptoms and poor quality of life. It is frequent …
disease, causing persistent respiratory symptoms and poor quality of life. It is frequent …
[HTML][HTML] Уважаемый посетитель! Эта информация для специалистов здравоохранения
ОУ Стецюк, ИВ Андреева, ИА Шевчик - medi.ru
Пероральный цефалоспорин III поколения цефподоксима проксетил доступен в
арсенале зарубежных врачей уже более 30 лет, однако, в отличие от других …
арсенале зарубежных врачей уже более 30 лет, однако, в отличие от других …
[PDF][PDF] Пероральный цефалоспорин III поколения цефподоксим в терапии респираторных инфекций
ОУ Стецюк, ИВ Андреева, ИА Шевчик - medi.ru
Oral 3rd generation cephalosporin cefpodoxime proxetil has been available in the antibiotic
armamentarium for more than 30 years, however, unlike other oral cephalosporins (eg …
armamentarium for more than 30 years, however, unlike other oral cephalosporins (eg …
Gemifloxacin
GM Eliopoulos - Kucers' The Use of Antibiotics, 2017 - taylorfrancis.com
Gemifloxacin, although technically a 6-fluoronaphthyridone, is usually considered among
the closely related fluoroquinolone class of antimicrobial agents. Originally designated …
the closely related fluoroquinolone class of antimicrobial agents. Originally designated …
[PDF][PDF] EVALUATION OF EFFICACY AND SAFETY OF GEMIFLOXACIN IN CHRONIC BRONCHITIS PATIENTS
SK Visoriya, S Muthusivam, J Jayasutha… - International Journal …, 2014 - researchgate.net
The study aimed to assess the efficacy and safety of Amoxicillin/Clavulanate 625 mg and
Amoxicillin/Clavulanate 1 gram in chronic bronchitis patients. Chronic bronchitis, a type of …
Amoxicillin/Clavulanate 1 gram in chronic bronchitis patients. Chronic bronchitis, a type of …
[PDF][PDF] Effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis
S Jaiswal - Journal of Advanced Medical and Dental Sciences …, 2017 - jamdsr.com
Background: Acute exacerbation of chronic bronchitis (AECB) refers to a sudden worsening
of symptoms in individuals with chronic bronchitis, which is characterized by inflammation …
of symptoms in individuals with chronic bronchitis, which is characterized by inflammation …
A systematic evaluation of the outcome measures reported in randomized
AG Mathioudakis, M Moberg, J Janner… - Intensive Care …, 2015 - Eur Respiratory Soc
1. Ma Z, Zhang W. Short-term versus longer duration of glucocorticoid therapy for
exacerbations of chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2016 Aug 6 …
exacerbations of chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2016 Aug 6 …